Purified rat Leydig tumour cells were pretreated with lutropin and the effect on the subsequent response to lutropin was determined. Maximal cyclic AMP production was achieved with the same concentration of lutropin in control and lutropin-pretreated cells; however, the maximum stimulated level in pretreated cells was only 30% of controls.
imidoltriphosphate [p(NH)ppG] plus lutropin and NaF plus lutropin caused a 50-60-fold linear increase in cyclic AMP production over 40min compared with 15-fold with p(NH)ppG and 6-fold with lutropin alone. In plasma membranes isolated from lutropin-treated cells the NaF-plus-lutropin-and the p(NH)ppG-stimulated cyclic AMP production rates were unchanged but no effect of lutropin could be demonstrated with or without added p(NH)ppG. In contrast the plasma membranes from dibutyryl cyclic AMP-treated cells had similar cyclic AMP production rates to control cells with all stimulants studied. The present evidence obtained from studies both with intact cells and with isolated plasma membranes indicates that the initial lutropin-induced desensitization of the rat Leydig tumour cell is due to a lesion in the hormone-receptor coupling to the guanine nucleotide regulatory protein. This process is apparently not mediated by cyclic AMP. The initial action of lutropin or choriogonadotropin on the testis Leydig cell is to stimulate steroidogenesis, a response that is mediated through the production of cyclic AMP (Cooke et al., 1976; tropin also cause a refractoriness or desensitization of that same steroidogenic response (Catt et al., 1979) . This hormone-induced loss of lutropin responsiveness may involve a loss of plasmamembrane receptor for lutropin (Hsueh et al., 1977; Sharpe, 1977; Purvis et al., 1977; Haour & Saez, 1977) , an uncoupling of the lutropin receptor from the adenylate cyclase (Saez et al., 1978; Jahnsen et al., 1981) , an increase in the metabolism of cyclic AMP due to increased phosphodiesterase activity (Purvis & Hansson, 1978) and a decrease in the activities of some of the enzymes in the steroidogenic pathways from pregnenolone to testosterone (Tsuruhara et al., 1977) . All of these studies have been carried out in vivo. To study the mechanisms involved we have investigated the effects of lutropin in vitro, using cells from a Leydig cell tumour, which have similar characteristics to normal Leydig cells (Cooke et al., 1979) . It was found that exposure of these cells to lutropin caused a decrease in lutropin-stimulated cyclic AMP production, which was followed by an apparent loss of lutropin receptors. These desensitizing effects of lutropin were prevented by the addition of the protein-synthesis inhibitor cycloheximide (Dix & Cooke, 1981 In the present study the site and mechanism of the lesion of lutropin desensitized adenylate cyclase in intact cells has been investigated. The lutropin and cholera-toxin-induced cyclic AMP production of lutropin and dibutyryl cyclic AMP-treated cells and the adenylate cyclase activity of plasma membranes isolated from these cells incubated with a combination of lutropin, p(NH)ppG and NaF were determined. Specific 125I-labelled human choriogonadotropin binding was measured in these pretreated cells after washing under acidic conditions to remove previously bound lutropin. Choriogonadotropin and the 2-O-succinyltyrosine methyl ester derivative of cyclic AMP were radioiodinated and characterized as previously described (Dix & Cooke, 1981) .
Materials and methods

Preparation oftumour Leydig cells
The Leydig tumour used for these studies has been previously characterized (Cooke et al., 1979) . The Leydig tumour was grown in Fischer rats and the cells isolated and purified using Percoll density gradients as previously described (Dix & Cooke, 1981) except that the collagenase dispersion step in the isolation procedure was omitted and the tumour fragments were dispersed by repeated aspiration through a 50ml syringe as described by Schumacher et al. (1979) for the dispersion of mouse testis cells. Cells with a density of 1.070 g/ml were used in all studies.
Cell incubation
The 1-methylxanthine (0.5 mM) with or without lutropin (0.1-100,ug/ml) or a maximal concentration of cholera toxin (4,g/ml) for 0-2h at 320C. At the end of the incubation period cyclic AMP was extracted from the cells by addition of HC104 (final concentration 0.5 M) and then neutralized with K3PO4 (final concentration 0.23 M). Cyclic AMP was then determined by radioimmunoassay by the method of Steiner et al. (1972) modified by the acetylation procedure described by Harper & Brooker (1975) .
Where indicated, cells were taken after preincubation and incubated for 2min at 0-40C in 0.9% saline containing 50mM-glycine, pH 3.0 or pH7.4. After this 2min incubation period the cells were diluted (1:25) with phosphate-buffered saline [0.01 M-phosphate buffer + 0.9% (w/v) NaCl + 0.1% (w/v) bovine serum albumin, pH7.41, centrifuged (200g for 10min), resuspended in phosphatebuffered saline and 125I-labelled choriogonadotropin binding determined using a single concentration saturation assay the details of which have been described previously (Dix & Cooke, 1981) .
Preparation ofplasma membranes
The pre-incubated cells were sedimented, resuspended in bicarbonate buffer (1.OmM-NaHCO3, 1.OmM-dithiothreitol and 2mM-MgCl2, pH 7.0) allowed to swell for 2.5 min and homogenized with five strokes in a Dounce homogenizer with a tight-fitting pestle. The homogenate was immediately brought to iso-osmolarity by the addition of sucrose (final concentration 0.25 M). Plasma membranes were then isolated with the aid of a two-phase poly(ethylene glycol)/Dextran system, which was originally described by Brunette & Till (1971) production was achieved in control and lutropinpretreated cells with l,ug of lutropin; however, the maximum stimulated level of pretreated cells was only 300/o of that of control cells (Fig. 1) . In other experiments (results not shown) this decreased maximum varied between 22 and 40%. The sensitivity to lutropin was decreased in lutropin-pretreated cells with an ED50 (dose that produces a response that is 50% of the maximal response) value estimated from dose-response curves of 60.0 + 5.7 ng/ml for pretreated cells compared with 8.4 + 1.8 ng/ml (mean + S.D.; n = 3) for control cells (Fig. 1) . Kinetic studies indicate that the reduced capacity of lutropin-pretreated cells to accumulate cyclic AMP was due to a decreased rate of production (Fig. 2) . Although the initial levels of cyclic AMP were higher in pretreated cells the subsequent basal and lutropin-induced cyclic AMP production was greatly reduced compared with control cells (0.38 and 1.89pmol/106 cells per min respectively for controls; and 0.08 and 0.58pmol/ 106 cells per min respectively for lutropin-pretreated cells). The decreased lutropin-stimulated cyclic AMP production is still evident 6 h after the pre-incubation (Fig. 3) , which is in agreement with previous observations (Dix & Cooke, 1981) . However, cholera-toxin-stimulated cyclic AMP production is not decreased by lutropin pre-incubation (Fig. 3) and a significant potentiation of the cholera-toxinstimulated cyclic AMP production can be seen at all time points studied (Fig. 3) .
In further experiments, purified Leydig tumour cells were pre-incubated with lutropin or dibutyryl cyclic AMP followed by preparation of the plasma membranes. The adenylate cyclase activity of the plasma membranes in the presence of lutropin, p(NH)ppG, lutropin plus p(NH)ppG and NaF plus lutropin were determined. In addition the lutropinand cholera-toxin-stimulated cyclic AMP production of the intact cells with and without acid washing were determined. In these experiments the cells were pre-incubated for 2h with a higher concentration of lutropin (lO,ug/ml) than in previous experiments.
Under these conditions, although the mean choleratoxin-stimulated cyclic AMP production was consistently higher in the lutropin-pretreated cells these values were not significantly different from control values (Tables 1 and 2 ; P > 0.05). In agreement with the previous experiments with lutropin pretreatment, there was no decrease in the cholera-toxinstimulated cyclic AMP production, whereas there was a decrease in the subsequent lutropin-stimulated cyclic AMP production (Tables 1 and 2) . Pre-incubation with dibutyryl cyclic AMP (2 mM) had no effect on either lutropin or cholera-toxinstimulated cyclic AMP production ( Table 1 . The effect oflutropin on the lutropin-receptor content and the cyclic AMP production ofLeydig tumour cells Leydig tumour cells prepared as described in the Materials and methods section were pre-incubated with or without lutropin (10.0ug/ml) for 2h at 320C. Cells were then centrifuged (200g for 10min) and incubated in 0.9% NaCl/ 50mM-glycine at 0-40C for 2min at pH 3.0 or 7.4. The cells were then washed in phosphate-buffered saline (pH 7.4) and specific '25I-labelled human choriogonadotropin binding and basal and lutropin-(lO,g/ml) and cholera-toxin-(4,ug/ml) stimulated cyclic AMP production were determined. Results Table 2 . The effect oflutropin and dibutyryl cyclic AMP pretreatment on cyclic AMP production Leydig cells prepared as described in the Materials and methods section were pre-incubated with lutropin (lO,g/ml), dibutyryl cyclic AMP (2mM) or saline for 2h at 320C. Cells were then washed twice in suspension medium and finally resuspended in suspension medium containing isobutylmethylxanthine (0.5 mM) and the basal and lutropin-(lOpg/ml) and cholera-toxin-(4,g/ml) stimulated cyclic AMP production were determined. Fig. 4 . Effect ofpretreatment ofLeydig tumour cells on the plasma-membrane adenylate cyclase activity Purified rat Leydig tumour cells were purified as described in the Materials and methods section and incubated for 2h at 320C in the presence of (a) suspension media, (b) lutropin (lOpg/ml) and (c) dibutyryl cyclic AMP (2mM). Cells were then washed and plasma membranes prepared and the basal (0), lutropin-(0; lug/ml), p(NH)ppG-(Al O.1mM), lutropin-(lug/ml) plus p(NH)ppG-(O.1mM) (A) and the fluoride-(10mM) plus lutropin-(1,ug/ml) (U) stimulated cyclic AMP production determined as described in the Materials and methods section. Results are means + S.E.M. (represented by the bars) for triplicate determinations.
by pre-incubation with lutropin (Table 1) . This decrease was abolished if the cells were washed under acidic conditions (pH 3.0 for 2 min at 0.-40C) ( Table  1) . Although this acid-washing procedure reversed the lutropin-induced decrease in specific '23I-labelled human choriogonadotropin binding it had no effect on the lutropin-induced decrease in lutropin-stimulated cyclic-AMP production of these cells ( However, the slight potentiation in cholera-toxinstimulated cyclic AMP production seen in lutropinpretreated cells was reversed by this acid-washing procedure (Table 1) . The results with purified plasma membranes from lutropin and dibutyryl cyclic-AMP pretreated cells are consistent with the results from intact cells. In plasma membranes from control cells both lutropin plus p(NH)ppG and NaF plus lutropin caused a 50-60-fold linear increase in cyclic AMP production over 40min compared with 15-fold with p(NH)ppG and 6-fold with lutropin alone (Fig. 4a) . In the plasma membranes isolated from lutropinpretreated cells the p(NH)ppG-and NaF-stimulated cyclic AMP production rates were not significantly different from those of control plasma membranes, but no effect of lutropin could be demonstrated with or without the addition of p(NH)ppG (Fig. 4b) . The plasma membranes from the dibutyryl cyclic AMPpretreated cells had similar cyclic AMP production rates to the control cells with all the stimulants studied (Fig. 4c) .
Discussion
Evidence obtained previously from studies in vivo suggested that a lesion between the lutropin receptor and the adenylate cyclase moiety develops in the rat testis Leydig cell after administration of human choriogonadotropin (Tsuruhara et al., 1977; Saez et al., 1978; Jahnsen et al., 1981) . Similar conclusions were reached with ovarian cells (Hunzicker-Dunn & Birnbaumer, 1976; Lamprecht et al., 1977) . The work carried out in the present study defines more clearly the site of this lesion as being between the guanine nucleotide-binding protein and the lutropin receptor under conditions where no loss in lutropin receptor sites occurred.
In the work of Tsuruhara et al. (1977) it was observed that cyclic AMP responses to cholera toxin were retained in testis interstitial cells from human choriogonadotropin-treated rats. In these studies the response to cholera toxin was measured 2 days after human choriogonadotropin treatment at a time when there had been a decrease in lutropin receptor levels. However, with the lowest dose of human choriogonadotropin used (0.2pg) that caused a loss in lutropin receptors there had been no decrease in the response to human choriogonadotropin with respect to cyclic AMP production, indicating that the hormone receptors were still able to couple to the guanine nucleotide regulatory protein. In contrast, in the present study it has been shown that, under conditions where the apparent number of hormone-binding sites is unaltered, lutropin produced a decrease in lutropin stimulation of adenylate cyclase in both intact cells and purified plasma membranes, whereas the cholera toxin response of intact cells and the fluoride and p(NH)ppG responses of purified plasma membranes were not decreased.
Although the mechanism of receptor-cyclase coupling is not fully understood, a guanine nucleotide-dependent regulatory protein is known to be involved (Ross & Gilman, 1980) . Since it has been shown that cholera toxin exerts its action through ADP ribosylation of this regulatory protein (Gill, 1977; Cassel & Pfeuffer, 1978) and p(NH)ppG activates the adenylate cyclase through this regulatory protein, the present results clearly demonstrate that the coupling between the regulatory protein and the adenylate cyclase moiety is intact in lutropin-desensitized cells. They furthermore suggest that the lesion lies at, or proximal to, the coupling of the guanine nucleotide regulatory protein to the lutropin receptor. Such a conclusion is in agreement with those of other workers investigating the isoprenaline-induced desensitization of S49 lymphoma cells (Iyengar et al., 1981; Green & Clark, 1981) . This lesion may be necessary before the internalization of the hormone-receptor complex can occur (Ascoli & Puett, 1977; Conn et al., 1978) .
Although little is known of the molecular events that cause desensitization, Hunzicker-Dunn et al. (1979) and Ezra & Salomon (1980) have suggested that desensitization of the ovarian adenylate cyclase system by lutropin involves a phosphorylation reaction. It is of interest to speculate that lutropininduced desensitization of rat Leydig tumour cells involves phosphorylation either of the lutropin receptor or of the guanine nucleotide-dependent regulatory protein, and that this phosphorylation impairs the coupling between the hormone receptors and the regulatory protein. However, in the present experiments dibutyryl cyclic AMP did not cause desensitization of the Leydig cells and therefore if a phosphorylation step is involved it appears not to be cyclic AMP-mediated. Experiments carried out with isolated Leydig cell tumour plasma membranes suggest that it may be GTP-mediated (S. N. Levi, M. Schumacher, C. J. Dix, M. G. Thomas & B. A. Cooke, unpublished work) . In contrast in mouse Leydig cells (Schumacher et al., 1981) gonadotropin-induced desensitization of the cyclic AMP response appears to be a cyclic AMP-mediated event.
A further point of interest is that lutropindesensitized cells show an increased cholera-toxinstimulated cyclic AMP production (Tsuruhara et al., 1977 ; the present work). Similar potentiation of isoprenaline-stimulated cyclic AMP production in S49 lymphoma cells by cholera toxin has been reported (Insel et al., 1981) . Dufau et al. (1980) have shown that lutropin causes an increase in the availability of the binding sites for GTP on the regulatory protein in rat testicular cell membranes. Such as increase in GTP-binding sites may explain the potentiation of the action of cholera toxin in lutropin-desensitized Leydig tumour cells and the loss of this potentiation when the bound lutropin is removed.
In conclusion, the present study clearly indicates that the initial events of lutropin-induced desensitization involve an uncoupling of the lutropin receptor from the guanine nucleotide-dependent regulatory protein before any loss of lutropin receptors occurs. Whether these events are receptor specific or whether there is a reduced sensitivity to other ligands in the lutropin-densitized plasma membranes has yet to be determined, along with the detailed molecular events of this process. However, the ability to prepare large numbers of pure cells and pure plasma membranes from the tumour cells used should facilitate the elucidation of these molecular events.
